During the past decade, National Hospital Organization Kure Medical Center conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 6 clinical trials were completed, i.e. on average, 54.5% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Hospital Organization Kure Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 4 trials, followed by "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 4 trials sponsored, "GOG Foundation" with 3 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored and "Pfizer" with 3 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Hospital Organization Kure Medical Center" #1 collaborator was "NRG Oncology" with 4 trials as a collaborator, "National Cancer Institute (NCI)" with 4 trials as a collaborator, "Astellas Pharma Inc" with 2 trials as a collaborator, "Korean Cancer Study Group" with 2 trials as a collaborator and "Niigata University Medical & Dental Hospital" with 2 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "National Hospital Organization Kure Medical Center" are "Colorectal Cancer" (2 trials), "Fallopian Tube Clear Cell Adenocarcinoma" (2 trials), "Fallopian Tube Endometrioid Adenocarcinoma" (2 trials), "Fallopian Tube Mucinous Adenocarcinoma" (2 trials) and "Fallopian Tube Serous Adenocarcinoma" (2 trials). Many other conditions were trialed in "National Hospital Organization Kure Medical Center" in a lesser frequency.

Most popular intervention types in "National Hospital Organization Kure Medical Center" are "Drug" (28 trials), "Other" (9 trials), "Biological" (8 trials), "Radiation" (5 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (6 trials), "Paclitaxel" (6 trials), "Quality-of-Life Assessment" (6 trials), "Carboplatin" (5 trials) and "Placebo" (5 trials). Other intervention names were less common.

The vast majority of trials in "National Hospital Organization Kure Medical Center" are 20 trials for "All" genders, 10 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "National Hospital Organization Kure Medical Center". undefined are not yet recruiting, 2 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in National Hospital Organization Kure Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Hospital Organization Kure Medical Center, 1 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".